Mr Mohamed Salhab

About

Mr MOHAMED SALHAB. Consultant Surgical Oncologist – Breast Cancer Surgery PROFESSIONAL PROFILE Mr Mohamed Salhab is a Consultant Surgical Oncologist specialising in breast cancer surgery and oncoplastic breast reconstruction. He has extensive experience in the diagnosis and surgical management of breast cancer, combining advanced oncological techniques with reconstructive procedures to achieve optimal cancer control while maintaining breast form and function. He practices within the NHS at Bradford Teaching Hospitals NHS Foundation Trust and privately at The Yorkshire Clinic and Spire Elland Hospital. Mr Salhab graduated with an MD in 1996 and completed his core and higher surgical training in the United Kingdom before undertaking specialist oncoplastic breast surgery training in London, Yorkshire, Paris, and Brussels. In 2011, he was awarded a Master of Surgery (MS) from University of London for his research in breast cancer molecular biology. He also holds a Postgraduate Diploma in Oncoplastic Breast Surgery from University of East Anglia. He achieved his Certificate of Completion of Training (CCT) in 2013 and was appointed Consultant Oncoplastic Breast Surgeon at Bradford Teaching Hospitals NHS Foundation Trust. In addition to his clinical practice, Mr Salhab serves as an Honorary Clinical Senior Lecturer at University of Leeds, contributing to surgical education and research in breast cancer. CLINICAL EXPERTISE Mr Salhab specialises in: Breast cancer diagnosis and surgical treatment Breast-conserving surgery (lumpectomy) Mastectomy Sentinel lymph node biopsy Immediate and delayed breast reconstruction Risk assessment for hereditary breast cancer Management of benign breast conditions Cosmetic and corrective breast surgery Male breast conditions including gynaecomastia RESEARCH AND PUBLICATIONS Mr Salhab has an extensive academic portfolio with numerous peer-reviewed publications in breast cancer biology, surgical oncology, and reconstructive breast surgery. Selected Recent Publications Rehman S, Salhab M. The Role of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapies in Early-Stage Breast Cancer: Current Practices, Treatment De-escalation, and Future Prospects. Cureus. 2024;16(2):e55230. Glassman D, Hignett S, Rehman S, Linforth R, Salhab M. Adjuvant Endocrine Therapy for Hormone-positive Breast Cancer, Focusing on Ovarian Suppression and Extended Treatment: An Update. Anticancer Research. 2017;37(10):5329-5341. Shaheed SU, Tait C, Kyriacou K, Linforth R, Salhab M, Sutton C. Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer. Clinical Proteomics. 2018;15:3. Shaheed SU, Tait C, Kyriacou K, Mullarkey J, Burrill W, Patterson LH, Linforth R, Salhab M, Sutton CW. Nipple aspirate fluid – A liquid biopsy for diagnosing breast health. Proteomics Clinical Applications. 2017. Salhab M, Patani N, Mokbel K. Sentinel lymph node micrometastasis in human breast cancer: An update. Surgical Oncology. 2011;20(4):e195-206. Salhab M, Bismohun S, Mokbel K. Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery. BMC Women’s Health. 2010;10:28. Kulendran M, Salhab M, Mokbel K. Oestrogen-synthesising enzymes and breast cancer. Anticancer Research. 2009;29(4):1095-1099. Salhab M, Singh-Ranger G, Mokbel R, Jouhra F, Jiang WG, Mokbel K. Cyclooxygenase-2 mRNA expression correlates with aromatase expression in human breast cancer. Journal of Surgical Oncology. 2007;96(5):424-428. Salhab M, Reed M, Al Sarakbi W, Jiang WG, Mokbel K. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting clinical outcome in human breast cancer. Breast Cancer Research and Treatment. 2006;99(2):155-162. Salhab M, Jiang WG, Newbold RF, Mokbel K. Expression of telomere-associated genes in human breast cancer and correlation with clinical outcome. Breast Cancer Research and Treatment. 2008;109(1):35-46.